DONNA PRYOR: Open Payments
NPI 1639145386 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 43 payments from 16 companies in 2025. Trend: 2023 $712 · 2024 $546 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $183 |
| Janssen Biotech, Inc. | 7 | $170 |
| Incyte Corporation | 8 | $140 |
| ABBVIE INC. | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| UCB, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Surgenex LLC | 1 | $40 |
| Almirall LLC | 1 | $32 |
Products named: TREMFYA, OPZELURA, ILUMYA, SKYRIZI, DUPIXENT, Winlevi, Bimzelx, Sotyktu.
Industry payments across CA — which companies pay providers there.
